Guillaume C.
- Country
- France
- Department
- Dermatology Department
Research Overview
- A Phase 2 Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LAD328 in Adults with Moderate to Severe Hidradenitis Suppurativa
- INCB 18424-320: A phase 3, double-blind, randomised, vehicle-controlled, efficacy and safety study of ruxolitinib cream in participants with Prurigo Nodularis. Topical ruxolitinib evaluation in Prurigo Nodularis (TRuE-PN2)
- Comparison of Adjustable Versus Standard Brodalumab Dosage Regimens in Patients with Moderate-to-Severe Plaque Psoriasis and Body Weight ≥120 kg
Data & Insights
Has run more than one trial at 86 of 212 partner sites.
Specializations
Inflammatory Skin Conditions
The investigator specializes in treating severe forms of plaque psoriasis and atopic dermatitis, with particular focus on managing these conditions in patients with specific therapeutic needs.
- Moderate-to-severe plaque psoriasis management
- Advanced atopic dermatitis treatment
- Weight-based therapeutic approaches
Their work encompasses innovative treatment strategies for challenging cases of inflammatory skin disorders.
Autoimmune Skin Disorders
Expertise in treating complex autoimmune conditions including pemphigus and mucous membrane pemphigoid, with emphasis on personalized therapeutic approaches.
- Severe pemphigus management
- Mucous membrane pemphigoid treatment
- Biomarker-based therapy optimization
Their focus includes developing targeted treatments for severe autoimmune skin manifestations.
Chronic Inflammatory Diseases
Dedicated to addressing challenging cases of hidradenitis suppurativa and erythema multiforme, exploring both established and emerging therapeutic options.
- Moderate to severe hidradenitis suppurativa
- Severe erythema multiforme
- Prurigo nodularis treatment
Their expertise extends to long-term management strategies for chronic inflammatory skin conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.